Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01122849 · ClinicalTrials.gov registry record · Phase 2
Exploratory Subjective Sleep Study of a Prototype Nasal Dilator
A Phase 2 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
NCT01122849 is a Phase 2 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 61 participants.
The verdict
NCT01122849, a Phase 2 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this exploratory study is to evaluate the subjective measures of congestion and sleep quality in subjects who suffer from chronic nasal congestion and report trouble with their sleep.
Interventions
- DEVICE Marketed Nasal Strip
- DEVICE Prototype Nasal Dilator
- DEVICE Placebo Nasal Strip
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2009-10-01 |
| Est. Completion | 2010-02-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01122849
The ClinicalTrials.gov registry entry for NCT01122849 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Marketed Nasal Strip is the first listed.
NCT01122849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01122849 about?
NCT01122849 is a clinical study titled "Exploratory Subjective Sleep Study of a Prototype Nasal Dilator". The purpose of this exploratory study is to evaluate the subjective measures of congestion and sleep quality in subjects who suffer from chronic nasal congestion and report trouble with their sleep.
What is the current status of trial NCT01122849?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2009-10-01. Estimated completion is 2010-02-01.
What interventions are being tested in trial NCT01122849?
The interventions under investigation include: Marketed Nasal Strip (DEVICE), Prototype Nasal Dilator (DEVICE), Placebo Nasal Strip (DEVICE).
Who is sponsoring clinical trial NCT01122849?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.